Description of Research Expertise:
1. Reirradiation with Proton Therapy: He is the Principal Investigator for the ongoing multicenter clinical study "Proton Radiotherapy for Recurrent Tumors" (ClinicalTrials.gov Identifier: NCT01126476). He is interested in factors that increase the risk of toxicity from reirradiation as well as factors that predict for radioresistance in these recurrent tumors.
2. Decreasing Toxicity of Lymphoma Radiotherapy: Interests include developing proton radiotherapy techniques for patients with lymphoma, developing models for predicting radiation-related toxicity, and using highly conformal techniques.
3. Using Moleclar Imaging to Estimate Radiation Dose during Radioimmunotherapy.
4. Proton therapy for gastrointestinal (GI) malignancies: He is the Principal Investigator for the clinical study "Proton therapy for upper GI cancers" (ClinicalTrials.gov Identifier: NCT01449864)
D Guttmann, N Mitra, J Metz, J Plastaras, W Feng, S Swisher-McClure: Neoadjuvant chemoradiation is associated with improved overall survival in elderly patients with esophageal cancer Journal of Geriatric Oncology : 2017.
D Guttmann, M Frick, R Carmona, C Deville Jr., W Levin, A Berman, C Chinniah, S Hahn, J Plastaras, C Simone II: A prospective study of proton reirradiation for recurrent and secondary soft tissue sarcoma Radiotherapy and Oncology (The Green Journal) : 2017.
Y Tseng, D Cutter, J Plastaras, R Parikh, O Cahlon, M Chuong, K Dedeckova, M Kahn, S Lin, L McGee, E Shen, S Terezakis, S Badiyan, Y Kirova, R Hoppe, N Mendenhall, M Pankuch, S Flampouri, U Ricardi, B Hoppe: Evidence-Based Review on the Utilization of Proton Therapy in Lymphoma from the Particle Therapy Cooperative Group Lymphoma Subcommittee International Journal of Radiation Oncology, Biology, Physics : 2017.
S. Dhakal, R. Advani, L. Ballas, B. Dabaja, C. Flowers, C. Ha, b. Hoppe, N. Mendenhall, M. Metzger, J. Plastaras, K. Roberts, R. Shapiro, S. Smith, S. Terezakis, K. Winkfield, A. Younes and L. Constine.: ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II American Journal of Clinical Oncology 39 (6): 535,2016.
K Winkfield, R Advani, L Ballas, B Dabaja, S Dhakal, C Flowers, C Soo Ha, B Hoppe, D Mansur, N Mendenhall, M Metzger, J Plastaras, K Roberts, R Shapiro, S Smith, S Terezakis, A Younes, L Constine: ACR Appropriateness Criteria® Recurrent Hodgkin Lymphoma The Oncology Journal : 2016.
Fernandes Annemarie, Berman Abigail T, Mick Rosemarie, Both Stefan, Lelionis Kristi, Lukens John N, Ben-Josef Edgar, Metz James M, Plastaras John P: A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer. International journal of radiation oncology, biology, physics 95 (1): 483-7,2016.
Datta Jashodeep, McMillan Matthew T, Ruffolo Luis, Lowenfeld Lea, Mamtani Ronac, Plastaras John P, Dempsey Daniel T, Karakousis Giorgos C, Drebin Jeffrey A, Fraker Douglas L, Roses Robert E: Multimodality Therapy Improves Survival in Resected Early Stage Gastric Cancer in the United States. Annals of surgical oncology : 2016.
Zeng C, Plastaras JP, James P, Tochner Z, Hill-Kayser C, Hahn S, and Both S: Proton Pencil Beam Scanning for Mediastinal Lymphoma: Treatment Planning and Robustness Assessment Acta Oncologica In Press : 2016.
Dhakal S, Advani R, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS: ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II American Journal of Clinical Oncology : 2016.
Datta Jashodeep, McMillan Matthew T, Ecker Brett L, Karakousis Giorgos C, Mamtani Ronac, Plastaras John P, Giantonio Bruce J, Drebin Jeffrey A, Dempsey Daniel T, Fraker Douglas L, Roses Robert E: Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis. Annals of surgery : 2015.